Local heparin delivery prior to coronary stent implantation: Acute and six-month clinical and angiographic results

Catheterization and Cardiovascular Diagnosis

Volumn 42, Issue 3, 1997, Pages 313-320

  Bartorelli, Antonio L ^a,d   De Cesare, Nicoletta B ^a   Kaplan, Aaron V ^b,c   Fabbiocchi, Franco ^a   Montorsi, Piero ^a   Squadroni, Lidia ^a   Galli, Stefano ^a   Sganzerla, Paolo ^a   Loaldi, Alessandro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b STANFORD UNIVERSITY   (United States)

^c LocalMed Inc   (United States)

^d Istituto di Cardiologia   (Italy)

Author keywords

Heparin; Local drug delivery; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE MB; DIPYRIDAMOLE; GLYCERYL TRINITRATE; HEPARIN; TICLOPIDINE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DISSECTION; ARTERY SPASM; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG INFUSION; HEART INFARCTION; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RESTENOSIS; SMOOTH MUSCLE FIBER; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CATHETERIZATION, PERIPHERAL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 0030826046     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199711)42:3<313::AID-CCD21>3.0.CO;2-L     Document Type: Article

References (33)

1. Landau C, Lange RA, Hillis LD: Percutaneous transluminal coronary angioplasty. New Engl J Med 330:981-993, 1994.
2. Clowes AW, Karnovsky MJ: Suppression of heparin of smooth muscle cell proliferation in injured arteries. Nature 265:652-656, 1977.
3. Hoover RL, Rosenberg RD, Haering W, Karnovsky MJ: Inhibition of rat arterial smooth muscle cell proliferation by heparin II: In vitro studies. Circ Res 47:578-583, 1980.
4. Clowes AW, Clowes MM: Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest 52:611-616, 1985.
5. Edelman ER, Karnovsky MJ: Contrasting effects of intermittent and continuous administration of heparin in experimental restenosis. Circulation 89:770-776, 1994.
6. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III: Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117:777-782, 1989.
7. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M: A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495, 1994.
8. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberger S: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501, 1994.
9. Hoffmann R, Mintz G, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 94:1247-1254, 1996.
10. Moura A, Lam JYTM, Hébert D, Kermode JR, Grant GW, Robitaille D, Klein EJ, Yock PG, Simpson JB, Kaplan AV: Intramural delivery of agent via a novel drug-delivery sleeve: Histologic and functional evaluation. Circulation 92:2299-2305, 1995.
11. Lincoff AM, Gottsauner-Wolf M, Jang Y, Grant G, Cohen JC, Penn MS, Chisolm GM, Kaplan AV, Ellis SG: Assessment of local drug delivery by the InfusaSleeve following coronary artery injury (abstract). Circulation 92:I-671, 1995.
12. Tanguay JF, Kruse KR, Kaplan AV, Armstrong BA, Grant GW, Virmani R, Phillips HR, Zidar JP: Local delivery of heparin prior to intracoronary stenting reduces platelet deposition (abstract). J Am Coll Cardiol 27:85A, 1996.
13. Tarazona N, Kaplan AV, Taylor MA, Grant GW, Malosky SA, Santoian EC: Local delivery of heparin via an infusion sleeve reduces neointimal proliferation in a swine coronary model. Cathet Cardiovasc Diagn 1997 (submitted).
14. Kaplan AV, Vandormael M, Bartorelli A, Hofmann M, Stoerger H, Simpson JB, Reifart N: Heparin delivery at the site of angioplasty with a novel drug delivery sleeve: Initial clinical series (abstract). J Am Coll Cardiol 25:286A, 1994.
15. Kaplan AV, Vandormael M, Hofmann M, Stoerger H, Gallant P, Simpson JB, Reifart N: Heparin delivery at the site of angioplasty with a novel drug delivery sleeve. Am J Cardiol 77:307-310, 1996.
16. Kaplan AV: Infusion sleeve catheter. Semin Interv Cardiol 1:36-38, 1996.
17. Kuntz RE, Baim DS: Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 88:1310-1323, 1993.
18. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol E, Bulle TM, and the Multivessel Angioplasty Prognosis Study Group: Coronary morphology and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation 82:1193-1202, 1990.
19. Coronary artery angiographic changes after PTCA: Manual of operations. NHLBI PTCA Registry 6-9, 1985.
20. Wallenstein S, Zucker C, Fleiss J: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980.
21. Castellot J, Cochran D, Karnovsky M: Effect of heparin on vascular smooth muscle cell. I: Cell metabolism. J Cell Physiol 124:21-28, 1985.
22. Castellot JJ, Addonizio ML, Rosenberg RD, Karnovsky MJ: Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 90:372-379, 1981.
23. Edelman ER, Adams DH, Karnovsky MJ: Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 87:3773-3777, 1990.
24. Majesky MW, Schwartz SM, Clowes MM, Clowes AW: Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 61:296-300, 1987.
25. Snow AD, Bolender RP, Wight TN, Clowes AW: Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 137:313-330, 1990.
26. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, Califf R, Dorosti K, Topol E, Gordon JB, Ohmen M, and the ERA investigators: Low molecular weight heparin in the prevention of restenosis after angioplasty. Results of enoxaparin restenosis (ERA) trial. Circulation 90:908-914, 1994.
27. Serruys PW, Enanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA: Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study. Circulation 93:412-422, 1996.
28. Kunz RE, Gibson MC, Nobuyoshy M, Baim DS: Generalized model of restenosis after conventional balloon angioplasty, stenting, and directional atherectomy. J Am Coll Cardiol 21:15-25, 1993.
29. Foley JB: Alterations in reference vessel diameter following intracoronary stent implantation: Important consequences for restenosis based on percent diameter stenosis. Cathet Cardiovasc Diagn 35:103-109, 1995.
30. Foley DP, Deckers J, van Den Bos AA, Heyndrickx GR, Laarman GJ, Suryapranata H, Zijlstra F, Serruys PW: Uselfuness of repeat coronary angiography 24 hours after successful balloon angioplasty to evaluate early luminal deterioration and facilitate quantitative analysis. Am J Cardiol 72:1341-1347, 1993.
31. Camenzind E, Kint PP, Di Mario C, Ligthart J, van den Giessen W, Boersma E, Serruys PW: Intracoronary heparin delivery in humans. Acute feasibility and long-term results. Circulation 92:2463-2472, 1995.
32. Glazier JJ, Eldin AM, Mitchel JF, Kiernan FJ, Hirst JA, Fram DB, Primiano CA, Vann B, Lynch K, Waters DD, McKay RG: Site-specific thrombolysis with urokinase-coated balloons. Results in 96 patients (abstract). Circulation 92:I-784, 1995.
33. Steg PG, Spaulding C, Makowski S, Feldman LJ, Barry JJ, for the CORAMI Study Group: A double blind randomized trial of hydrogel balloon delivery of urokinase during primary angioplasty for acute myocardial infarction (abstract). Circulation 92:I-543, 1995.